A drug that has been used to treat liver disease for decades may help to restore cells damaged by Alzheimer’s disease, a new study has revealed.
Browsing: drug repurposing
A novel study reveals that low-dose aspirin may aid the removal of Alzheimer’s-related amyloid plaques, indicating a potential new role for this medication.
New study examines the combinational effect of traditional and repurposed drugs in the treatment of dementia with Lewy bodies.
A new study on mice has demonstrated that lithium chloride can impede the detrimental effects of fetal alcohol syndrome on the developing brain.
Researchers have uncovered the role of cellular prion protein (PrPC) in Neurofibromatosis Type 2 (NF2) related tumors, offering hope to neuro-tumor patients.
Researchers discover that the drug, pyrimethamine, may reduce disease progression in patients with inherited amyotrophic lateral sclerosis (ALS).
We caught up with Regina Katzenschlager at AAN 2017, whose research into the use of apomorphine for Parkinson’s disease was highlighted at the conference as one to watch.
Both lithium and rapamycin could prevent the secondary nerve cell damage caused by the overproduction of glutamate after a traumatic brain injury.
Two anticancer and antidepressant drugs have been found to block a translational repression pathway that has previously been linked to neurodegeneration.
In this interview, we speak to Elena Minakova, a Fellow in Neonatology at UCLA who is investigating a role for Melanotan-II in reducing social deficits in autism.